Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

OBJECTIVES: To evaluate the relationship between bone mineral density (BMD) and biomarkers of bone turnover and inflammation in patients with ankylosing spondylitis (AS) treated with infliximab. METHODS: Patients (n = 279) were randomly assigned (3:8) to receive placebo or 5 mg/kg infliximab every 6...

Full description

Saved in:

Bibliographic Details
Main Authors:	Visvanathan, S, van der Heijde, D, Deodhar, A, Wagner, C, Baker, D G, Han, J, Braun, J
Format:	Artigo
Language:	Inglês
Published:	BMJ Publishing Group 2008
Subjects:	Clinical and Epidemiological Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2605572/ https://ncbi.nlm.nih.gov/pubmed/18495735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.084426
Tags:	Add Tag No Tags, Be the first to tag this record!

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

Similar Items